{"id":709,"date":"2026-01-22T02:31:23","date_gmt":"2026-01-22T00:31:23","guid":{"rendered":"https:\/\/www.transtoyou.com\/et\/?post_type=tty_blog&#038;p=709"},"modified":"2026-01-22T02:31:23","modified_gmt":"2026-01-22T00:31:23","slug":"kaalu-langetamise-medicina-voimaluste-vordlemine","status":"publish","type":"tty_blog","link":"https:\/\/www.transtoyou.com\/et\/blog\/krooniline-metaboolne-tervis\/kaalu-langetamise-medicina-voimaluste-vordlemine\/","title":{"rendered":"Kaalulangetamise ravimid: parimate valikute v\u00f5rdlus"},"content":{"rendered":"<p>Kaalulangetamise ravimid nagu Mounjaro (tirzepatide) ja Ozempic (semaglutide) on populaarsust kogunud oma t\u00f5hususe t\u00f5ttu rasvumise juhtimisel. See juhend uurib nende mehhanisme, kaalulangetamise tulemusi, k\u00f5rvaltoimeid ja sobivust, et aidata sul otsustada, milline neist v\u00f5iks olla sinu jaoks \u00f5ige.<\/p>\n<p>Gl\u00fckagoonitaoline peptiid-1 (GLP-1) on praegu \u00fcks k\u00f5ige lootustandvamaid bioloogilisi s\u00fcsteeme t\u00f5husate rasvumise farmakoteraapiate arendamiseks. Pikaajalised GLP-1 analoogid v\u00e4hendavad toidu tarbimist ja kehakaalu, ning hiljutised avastused n\u00e4itavad, et nende ravimite perifeerne manustamine v\u00e4hendab toidu tarbimist peamiselt humoraalsete teede kaudu, mis h\u00f5lmavad otsest toimet aju GLP-1 retseptoritele (GLP-1R).<\/p>\n<h2>Mounjaro vs Ozempic: Milline t\u00f6\u00f6tab paremini?<\/h2>\n<p><a class=\"always-open-new-tab\"   href=\"\/et\/product\/mounjaro\"   rel=\"nofollow\">Mounjaro<\/a> kasutab kahefaktorilist mehhanismi GIP ja GLP-1 retseptorite suhtes, samas kui <a class=\"always-open-new-tab\"   href=\"\/et\/product\/ozempic\"   rel=\"nofollow\">Ozempic<\/a> sihib ainult GLP-1 retseptoreid, mis toob kaasa erinevusi t\u00f5hususes. Kliinilised uuringud n\u00e4itavad, et Mounjaro v\u00f5ib olla t\u00f5husam kui Ozempic veresuhkru taseme juhtimisel ja kaalulangetamise edendamisel. Ozempic on heaks kiidetud suurte s\u00fcdame-veresoonkonna s\u00fcndmuste ja neeruhaiguse t\u00fcsistuste riskide v\u00e4hendamiseks, mis ei kehti Mounjaro kohta. M\u00f5lemad ravimid on pikaajalised s\u00fcstitavad ravimeetodid 2. t\u00fc\u00fcpi <a class=\"always-open-new-tab\"   href=\"\/et\/treatment\/diabetes\"   rel=\"nofollow\">diabeedi<\/a> jaoks, mida on m\u00f5eldud kasutamiseks koos elustiili muutustega, nagu tasakaalustatud toitumine ja f\u00fc\u00fcsiline aktiivsus.<\/p>\n<h2>Wegovy v\u00f5i Saxenda: Milline toob suuremat kaalulangust?<\/h2>\n<p>M\u00f5istetavalt soovivad enamik inimesi, kes valivad kaalulangetamise ravimeetodite vahel, teada, milline valik on k\u00f5ige t\u00f5husam. Kuigi tulemused varieeruvad s\u00f5ltuvalt sinu algkaalust, elustiilist ja toitumisest, peetakse <a class=\"always-open-new-tab\"   href=\"\/et\/product\/wegovy\"   rel=\"nofollow\">Wegovy<\/a> \u00fcldiselt t\u00f5husamaks kui <a class=\"always-open-new-tab\"   href=\"\/et\/product\/saxenda\"   rel=\"nofollow\">Saxenda<\/a>. \u00dches 68-n\u00e4dalasest uuringust n\u00e4idati, et peaaegu pooled t\u00e4iskasvanud (48%) Wegovy&#8217;t v\u00f5tnutest kaotasid umbes 15% oma algkaalust. Wegovy on n\u00fc\u00fcd \u00fcks tuntumaid ja populaarsemaid kaalulangetamise ravimeid. Kui sa v\u00f5tad Wegovy s\u00fcstide kujul, parandad oma toitumist ja suurendad f\u00fc\u00fcsilist aktiivsust, v\u00f5id esimesel raviaastal kaotada kuni 15% oma algkaalust.<\/p>\n<p>Wegovy toimeaine on Semaglutid. See j\u00e4ljendab hormooni nimega GLP-1, mida toodab sinu keha ja mis toimib retseptoritele ajus, et \u00f6elda sulle, et oled t\u00e4is. J\u00e4ljendades seda hormooni, suudab Semaglutid aktiveerida GLP-1 retseptori ja petta sinu keha arvama, et sa ei ole n\u00e4ljane. See v\u00f5ib v\u00e4hendada sinu isu ja muuta rasvased ja magusad toidud &#8211; mis on tavaliselt k\u00f5rge kalorsusega &#8211; v\u00e4hem ahvatlevaks.<\/p>\n<p>Saxenda sisaldab toimeainet nimega Liraglutid. See toimib samuti GLP-1 retseptoril, et v\u00e4hendada sinu isu ja aidata v\u00e4ltida \u00fcles\u00f6\u00f6mist. Uuringud on n\u00e4idanud, et Saxenda, koos suurenenud f\u00fc\u00fcsilise aktiivsuse ja paranenud toitumisega, v\u00f5iks aidata sul kaotada esimesel raviaastal 5% kuni 10% oma algkaalust.<\/p>\n<h2>Mysimba vs teised kaalulangetamise ravimid<\/h2>\n<p><a class=\"always-open-new-tab\"   href=\"\/et\/product\/mysimba\"   rel=\"nofollow\">Mysimba<\/a> (naltreksoon\/bupropioon) on kaalulangetamise ravim, mis erineb teistest valikutest nagu Semaglutid (Wegovy, Ozempic) ja Liraglutid (Saxenda) oma toime mehhanismi, k\u00f5rvaltoimete ja efektiivsuse poolest. Mysimba on kombinatsiooniravim, mis m\u00f5jutab aju keemiat, et v\u00e4hendada isu ja suurendada energia kulutamist, samas kui GLP-1 retseptori agonistid nagu Semaglutid ja Liraglutid toimivad, j\u00e4ljendades soolestikus hormooni, mis reguleerib isu ja veresuhkrut.<\/p>\n<p>Mysimba (Naltreksoon-bupropioon) v\u00e4hendab kehakaalu oluliselt, kuid suurendab m\u00e4rkimisv\u00e4\u00e4rselt k\u00f5rvaltoimete riski. N\u00f5utav on range turuj\u00e4rgse j\u00e4relevalve protsess. Peamised erinevused on:<\/p>\n<h4>Toime mehhanism<\/h4>\n<p>Mysimba toimib ajus, samas kui GLP-1 retseptori agonistid toimivad soolestikus.<\/p>\n<h4>Potentsiaalsed k\u00f5rvaltoimed<\/h4>\n<p>Kuigi m\u00f5lemal on sarnased seedetrakti k\u00f5rvaltoimed, v\u00f5ib Mysimbal olla k\u00f5rgem ps\u00fchhiaatriliste k\u00f5rvaltoimete risk.<\/p>\n<h4>Kaalulangetamise tulemused<\/h4>\n<p>GLP-1 retseptori agonistid n\u00e4itavad \u00fcldiselt suuremaid kaalulangetamise tulemusi kui Mysimba.<\/p>\n<h2>Teadus GLP-1 agonistide ja kaalulanguse taga<\/h2>\n<p>Gl\u00fckagoonitaolised peptiid-1 (GLP-1) agonistid on ravimite klass, mida kasutatakse 2. t\u00fc\u00fcpi diabeedi (T2DM) ja rasvumise raviks. Ravimite klassina on nad mitmete farmakoloogiliste valikute seas nende endokriinsete haiguste jaoks. GLP-1 agonistide funktsioon on alandada seerumi gl\u00fckoositaset ja seel\u00e4bi juhtida ainevahetust m\u00f5jutatud patsientidel.<\/p>\n<h3>Kuidas GLP-1 agonistid toimivad?<\/h3>\n<p>Et m\u00f5ista, kuidas GLP-1 agonistid toimivad, aitab m\u00f5ista, kuidas loomulikult esinev GLP-1 hormoon t\u00f6\u00f6tab. GLP-1 on hormoon, mida toodab peensool. Sellel on mitmeid rolle, sealhulgas:<\/p>\n<p>GLP-1 (gl\u00fckagoonitaoline peptiid-1) m\u00e4ngib olulist rolli veresuhkru ja isu reguleerimisel. See k\u00e4ivitab insuliini vabanemise k\u00f5hun\u00e4\u00e4rmest, aidates kehal toitu energiaks muuta, samal ajal alandades veresuhkru taset, ebapiisav insuliin v\u00f5ib viia k\u00f5rge veresuhkru ja diabeedini. Samal ajal blokeerib GLP-1 gl\u00fckagooni sekretsiooni, takistades liigse gl\u00fckoosi sattumist vereringesse. Lisaks aeglustab see mao t\u00fchjenemist, v\u00e4hendades gl\u00fckoosi imendumise kiirus toidust. Veresuhkru kontrolli k\u00f5rval suurendab GLP-1 k\u00fcllastust, toimides aju piirkondades, mis t\u00f6\u00f6tlevad n\u00e4ljasignaale, aidates inimestel p\u00e4rast s\u00f6\u00f6mist kauem t\u00e4is olla. Need kombineeritud efektid muudavad GLP-1 oluliseks sihtm\u00e4rgiks diabeedi ja kaaluhalduse ravimite jaoks.<\/p>\n<h2>Kaalulangetamise ravimi kaalumine<\/h2>\n<ul>\n<li>BMI v\u00f5rdne v\u00f5i suurem kui 30.<\/li>\n<li>BMI v\u00f5rdne v\u00f5i suurem kui 27 koos \u00fche v\u00f5i enama rasvumisega seotud seisundiga (nagu k\u00f5rge verer\u00f5hk v\u00f5i diabeet)<\/li>\n<li>Ei ole kaotanud v\u00e4hemalt 5% oma kogukaalust kolme kuni kuue kuu jooksul ainult elustiili muutustega.<\/li>\n<\/ul>\n<p>Ravimid nagu Mounjaro, Ozempic, Wegovy, Saxenda ja Mysimba toimivad erinevate mehhanismide kaudu, nagu GLP-1 retseptori aktiveerimine v\u00f5i aju keemia modulaator, et aidata kaalulangust koos elustiili muutustega. Tervishoiuteenuse osutaja saab hinnata individuaalseid tervisefaktoreid, et m\u00e4\u00e4rata k\u00f5ige sobivam valik.<\/p>\n<h2>Oodatav kaalulangus<\/h2>\n<p>Kui palju kaalu sa saad ohutult kaotada kuus, varieerub inimeselt inimesele. Siiski soovitavad enamik terviseeksperte ja meditsiinilisi organisatsioone kaalulangetamise eesm\u00e4rki 1-2 naela ehk lbs (2.2-4.4 kilogrammi ehk kg) n\u00e4dalas, mis v\u00f5rdub 4-8 naela (8.8-17.6 kg) kuus. See tempo aitab v\u00e4hendada t\u00fcsistuste riski ja parandab sinu v\u00f5imalusi kaalu p\u00fcsivalt hoida.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Kaalulangetamise ravimid nagu Mounjaro (tirzepatide) ja Ozempic (semaglutide) on populaarsust kogunud oma t\u00f5hususe t\u00f5ttu rasvumise juhtimisel. See juhend uurib nende&#8230;<\/p>\n","protected":false},"author":13,"featured_media":710,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"tags":[],"expert":[20],"tty_blog_category":[38],"tty_blog_tag":[],"class_list":["post-709","tty_blog","type-tty_blog","status-publish","has-post-thumbnail","hentry","expert-dr-m-ahmed","tty_blog_category-krooniline-metaboolne-tervis"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Kaalulangetamise ravimid: parimate valikute v\u00f5rdlus - Transtoyou - ET<\/title>\n<meta name=\"description\" content=\"V\u00f5rdle Mounjaro, Ozempic, Wegovy, Saxenda ja Mysimba kaalulangetamiseks \u2014 mehhanismid, tulemused, k\u00f5rvaltoimed ja kes kvalifitseerub.\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"et_EE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Kaalulangetamise ravimid: parimate valikute v\u00f5rdlus - Transtoyou - ET\" \/>\n<meta property=\"og:description\" content=\"V\u00f5rdle Mounjaro, Ozempic, Wegovy, Saxenda ja Mysimba kaalulangetamiseks \u2014 mehhanismid, tulemused, k\u00f5rvaltoimed ja kes kvalifitseerub.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.transtoyou.com\/et\/?post_type=tty_blog&amp;p=709\" \/>\n<meta property=\"og:site_name\" content=\"Transtoyou - ET\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.transtoyou.com\/wp-content\/uploads\/sites\/7\/2026\/01\/20251031_1005_Weight-Loss-Journey_remix_01k8wr4mq9fbb8f9r67hsn7edk.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"1024\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"5 minutit\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.transtoyou.com\/et\/?post_type=tty_blog&p=709\",\"url\":\"https:\/\/www.transtoyou.com\/et\/?post_type=tty_blog&p=709\",\"name\":\"Kaalulangetamise ravimid: parimate valikute v\u00f5rdlus - Transtoyou - ET\",\"isPartOf\":{\"@id\":\"https:\/\/www.transtoyou.com\/et\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.transtoyou.com\/et\/?post_type=tty_blog&p=709#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.transtoyou.com\/et\/?post_type=tty_blog&p=709#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.transtoyou.com\/et\/wp-content\/uploads\/sites\/7\/2026\/01\/20251031_1005_Weight-Loss-Journey_remix_01k8wr4mq9fbb8f9r67hsn7edk.png\",\"datePublished\":\"2026-01-22T00:31:23+00:00\",\"description\":\"V\u00f5rdle Mounjaro, Ozempic, Wegovy, Saxenda ja Mysimba kaalulangetamiseks \u2014 mehhanismid, tulemused, k\u00f5rvaltoimed ja kes kvalifitseerub.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.transtoyou.com\/et\/?post_type=tty_blog&p=709#breadcrumb\"},\"inLanguage\":\"et\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.transtoyou.com\/et\/?post_type=tty_blog&p=709\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"et\",\"@id\":\"https:\/\/www.transtoyou.com\/et\/?post_type=tty_blog&p=709#primaryimage\",\"url\":\"https:\/\/www.transtoyou.com\/et\/wp-content\/uploads\/sites\/7\/2026\/01\/20251031_1005_Weight-Loss-Journey_remix_01k8wr4mq9fbb8f9r67hsn7edk.png\",\"contentUrl\":\"https:\/\/www.transtoyou.com\/et\/wp-content\/uploads\/sites\/7\/2026\/01\/20251031_1005_Weight-Loss-Journey_remix_01k8wr4mq9fbb8f9r67hsn7edk.png\",\"width\":1024,\"height\":1024,\"caption\":\"Arsti n\u00f5uanne nutitelefonis: Kuidas kaotada kaalu koos ravimitega?\"},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.transtoyou.com\/et\/#website\",\"url\":\"https:\/\/www.transtoyou.com\/et\/\",\"name\":\"Transtoyou - ET\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.transtoyou.com\/et\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.transtoyou.com\/et\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"et\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.transtoyou.com\/et\/#organization\",\"name\":\"Transtoyou - ET\",\"url\":\"https:\/\/www.transtoyou.com\/et\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"et\",\"@id\":\"https:\/\/www.transtoyou.com\/et\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.transtoyou.com\/et\/wp-content\/uploads\/sites\/7\/2026\/01\/logo-tty-menu-bar-300x87-1.webp\",\"contentUrl\":\"https:\/\/www.transtoyou.com\/et\/wp-content\/uploads\/sites\/7\/2026\/01\/logo-tty-menu-bar-300x87-1.webp\",\"width\":300,\"height\":87,\"caption\":\"Transtoyou - ET\"},\"image\":{\"@id\":\"https:\/\/www.transtoyou.com\/et\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Kaalulangetamise ravimid: parimate valikute v\u00f5rdlus - Transtoyou - ET","description":"V\u00f5rdle Mounjaro, Ozempic, Wegovy, Saxenda ja Mysimba kaalulangetamiseks \u2014 mehhanismid, tulemused, k\u00f5rvaltoimed ja kes kvalifitseerub.","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"et_EE","og_type":"article","og_title":"Kaalulangetamise ravimid: parimate valikute v\u00f5rdlus - Transtoyou - ET","og_description":"V\u00f5rdle Mounjaro, Ozempic, Wegovy, Saxenda ja Mysimba kaalulangetamiseks \u2014 mehhanismid, tulemused, k\u00f5rvaltoimed ja kes kvalifitseerub.","og_url":"https:\/\/www.transtoyou.com\/et\/?post_type=tty_blog&p=709","og_site_name":"Transtoyou - ET","og_image":[{"width":1024,"height":1024,"url":"https:\/\/www.transtoyou.com\/wp-content\/uploads\/sites\/7\/2026\/01\/20251031_1005_Weight-Loss-Journey_remix_01k8wr4mq9fbb8f9r67hsn7edk.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"5 minutit"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.transtoyou.com\/et\/?post_type=tty_blog&p=709","url":"https:\/\/www.transtoyou.com\/et\/?post_type=tty_blog&p=709","name":"Kaalulangetamise ravimid: parimate valikute v\u00f5rdlus - Transtoyou - ET","isPartOf":{"@id":"https:\/\/www.transtoyou.com\/et\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.transtoyou.com\/et\/?post_type=tty_blog&p=709#primaryimage"},"image":{"@id":"https:\/\/www.transtoyou.com\/et\/?post_type=tty_blog&p=709#primaryimage"},"thumbnailUrl":"https:\/\/www.transtoyou.com\/et\/wp-content\/uploads\/sites\/7\/2026\/01\/20251031_1005_Weight-Loss-Journey_remix_01k8wr4mq9fbb8f9r67hsn7edk.png","datePublished":"2026-01-22T00:31:23+00:00","description":"V\u00f5rdle Mounjaro, Ozempic, Wegovy, Saxenda ja Mysimba kaalulangetamiseks \u2014 mehhanismid, tulemused, k\u00f5rvaltoimed ja kes kvalifitseerub.","breadcrumb":{"@id":"https:\/\/www.transtoyou.com\/et\/?post_type=tty_blog&p=709#breadcrumb"},"inLanguage":"et","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.transtoyou.com\/et\/?post_type=tty_blog&p=709"]}]},{"@type":"ImageObject","inLanguage":"et","@id":"https:\/\/www.transtoyou.com\/et\/?post_type=tty_blog&p=709#primaryimage","url":"https:\/\/www.transtoyou.com\/et\/wp-content\/uploads\/sites\/7\/2026\/01\/20251031_1005_Weight-Loss-Journey_remix_01k8wr4mq9fbb8f9r67hsn7edk.png","contentUrl":"https:\/\/www.transtoyou.com\/et\/wp-content\/uploads\/sites\/7\/2026\/01\/20251031_1005_Weight-Loss-Journey_remix_01k8wr4mq9fbb8f9r67hsn7edk.png","width":1024,"height":1024,"caption":"Arsti n\u00f5uanne nutitelefonis: Kuidas kaotada kaalu koos ravimitega?"},{"@type":"WebSite","@id":"https:\/\/www.transtoyou.com\/et\/#website","url":"https:\/\/www.transtoyou.com\/et\/","name":"Transtoyou - ET","description":"","publisher":{"@id":"https:\/\/www.transtoyou.com\/et\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.transtoyou.com\/et\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"et"},{"@type":"Organization","@id":"https:\/\/www.transtoyou.com\/et\/#organization","name":"Transtoyou - ET","url":"https:\/\/www.transtoyou.com\/et\/","logo":{"@type":"ImageObject","inLanguage":"et","@id":"https:\/\/www.transtoyou.com\/et\/#\/schema\/logo\/image\/","url":"https:\/\/www.transtoyou.com\/et\/wp-content\/uploads\/sites\/7\/2026\/01\/logo-tty-menu-bar-300x87-1.webp","contentUrl":"https:\/\/www.transtoyou.com\/et\/wp-content\/uploads\/sites\/7\/2026\/01\/logo-tty-menu-bar-300x87-1.webp","width":300,"height":87,"caption":"Transtoyou - ET"},"image":{"@id":"https:\/\/www.transtoyou.com\/et\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.transtoyou.com\/et\/wp-json\/wp\/v2\/tty_blog\/709","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.transtoyou.com\/et\/wp-json\/wp\/v2\/tty_blog"}],"about":[{"href":"https:\/\/www.transtoyou.com\/et\/wp-json\/wp\/v2\/types\/tty_blog"}],"author":[{"embeddable":true,"href":"https:\/\/www.transtoyou.com\/et\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/www.transtoyou.com\/et\/wp-json\/wp\/v2\/comments?post=709"}],"version-history":[{"count":1,"href":"https:\/\/www.transtoyou.com\/et\/wp-json\/wp\/v2\/tty_blog\/709\/revisions"}],"predecessor-version":[{"id":711,"href":"https:\/\/www.transtoyou.com\/et\/wp-json\/wp\/v2\/tty_blog\/709\/revisions\/711"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.transtoyou.com\/et\/wp-json\/wp\/v2\/media\/710"}],"wp:attachment":[{"href":"https:\/\/www.transtoyou.com\/et\/wp-json\/wp\/v2\/media?parent=709"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.transtoyou.com\/et\/wp-json\/wp\/v2\/tags?post=709"},{"taxonomy":"expert","embeddable":true,"href":"https:\/\/www.transtoyou.com\/et\/wp-json\/wp\/v2\/expert?post=709"},{"taxonomy":"tty_blog_category","embeddable":true,"href":"https:\/\/www.transtoyou.com\/et\/wp-json\/wp\/v2\/tty_blog_category?post=709"},{"taxonomy":"tty_blog_tag","embeddable":true,"href":"https:\/\/www.transtoyou.com\/et\/wp-json\/wp\/v2\/tty_blog_tag?post=709"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}